powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1245506237
Matthew Flynn
M.D.
Pulmonary Disease
Vancouver,
WA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 380091
Hospital
CCN 380103
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
962
Beneficiaries
—
Total drug cost
$415K
Distinct drugs
19
Brand share
63.6%
Top prescribed drugs
Fluticasone Propion/Salmeterol
159 claims
Azithromycin
128 claims
Prednisone
128 claims
Albuterol Sulfate
101 claims
Ciclesonide
84 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
13
Unique beneficiaries
—
Total services
21
Distinct HCPCS
1
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 228 Pulmonary Disease providers in WA — bottom quintile (cohort median 454).